7 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Chronic Obstructive Lung ... LAMA: long-acting ... #Management #Pulmonary ... COPD #GOLD2017 #LAMA
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... corticosteroid; LABA ... -agonist; LAMA, ... #LABA #LAMA #SABA ... #SAMA #ICS #Pharmacology
Long-Acting Dual Bronchodilators - LAMA/LABA Combo Inhalers 

The FDA approved a new dual bronchodilator (LABA/LAMA) combination
Bronchodilators - LAMA ... /LABA Combo Inhalers ... bronchodilator (LABA ... /LAMA) combination ... #LABA #Combo #Inhalers
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Triple Therapy (LAMA ... /LABA/ICS) - ... Bronchodilators (LAMA ... /LABA) & Eosinophils ... #Pharmacology #
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
The 2019 Global ... Asthma (GINA) treatment ... receptor antagonists; LABA ... : long-acting β2 ... Management #Stepwise #Pulmonary
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... murmur 3/6) - Pulmonary ... Change in clinical ... Determine if any labs ... unless prior heart/lung
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... salivary ducts Clinical ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic